NutriBand (NTRB) Liabilities and Shareholders Equity (2016 - 2026)
NutriBand's (NTRB) quarterly Liabilities and Shareholders Equity came in at $6.3 million in Q3 2026, down 38.16% year-over-year from $10.2 million in Q3 2025, and down 8.69% quarter-over-quarter from $6.9 million in Q2 2026.
Powered by 
Analysis
NutriBand (NTRB) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
NutriBand has disclosed Liabilities and Shareholders Equity across 11 years of filings, most recently posting $6.3 million for Q3 2026.
- In Q3 2026, Liabilities and Shareholders Equity fell 38.16% year-over-year to $6.3 million; the TTM figure through Jul 2026 stood at $29.2 million (down 19.78% YoY), while the FY2026 annual figure was $7.5 million, up 1.04% from the prior year.
- Liabilities and Shareholders Equity came in at $6.3 million for Q3 2026 at NutriBand, down from $6.9 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $15.2 million in Q2 2024 to a low of $6.2 million in Q2 2025.
- Average Liabilities and Shareholders Equity over 5 years is $9.7 million, with a median of $9.5 million recorded in 2023.
- Year-over-year, Liabilities and Shareholders Equity jumped 74.68% in 2024 and slumped 59.4% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $10.7 million in 2022, then fell by 20.12% to $8.5 million in 2023, then surged by 47.17% to $12.5 million in 2024, then plunged by 32.88% to $8.4 million in 2025, then declined by 25.25% to $6.3 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $6.3 million in Q3 2026, $6.9 million in Q2 2026, and $7.5 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 39.86 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 35.04 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 6.08 Bn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 3.78 Bn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 24.79 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 1.49 Bn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 1.59 Bn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 1.74 Bn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 75.75 Mn |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | 6.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 6.29 Mn |
| Apr 30, 2026 | 6.89 Mn |
| Jan 31, 2026 | 7.55 Mn |
| Oct 31, 2025 | 8.42 Mn |
| Jul 31, 2025 | 10.18 Mn |
| Apr 30, 2025 | 6.15 Mn |
| Jan 31, 2025 | 7.47 Mn |
| Oct 31, 2024 | 12.54 Mn |
| Jul 31, 2024 | 13.63 Mn |
| Apr 30, 2024 | 15.15 Mn |
| Jan 31, 2024 | 7.52 Mn |
| Oct 31, 2023 | 8.52 Mn |
| Jul 31, 2023 | 9.87 Mn |
| Apr 30, 2023 | 8.68 Mn |
| Jan 31, 2023 | 9.46 Mn |
| Oct 31, 2022 | 10.67 Mn |
| Jul 31, 2022 | 11.39 Mn |
| Apr 30, 2022 | 11.98 Mn |
| Jan 31, 2022 | 12.74 Mn |
| Oct 31, 2021 | 15.43 Mn |
API Access
NutriBand Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NTRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NTRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NTRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();